MGC Surpassed 2,000 Prescribed Units’ Milestone; First Shipment Arrived Successfully in Brazil

  • Jan 09, 2020 AEDT
  • Team Kalkine

MGC Pharmaceuticals Ltd (ASX:MXC) announced that it passed 2,000 prescribed units’ level of its standardised, affordable cannabinoid medicines.

The increase in the prescribed units was from the patients in Australia, the UK along with the recent additions of new patient special access approved markets of Brazil & Ireland after the recent approval for selling MGC Pharma products in these nations.

The company also confirmed the successful arrival of its first shipment in Brazil after an initial purchase order from ONIX Empreendimentos e Participações (‘Onix’) in November 2019.



All pictures are copyright to their respective owner(s) does not claim ownership of any of the pictures displayed on this website unless stated otherwise. Some of the images used on this website are taken from the web and are believed to be in public domain. We have used reasonable efforts to accredit the source (public domain/CC0 status) to where it was found and indicated it below the image.


There is no investor left unperturbed with the ongoing trade conflicts between US-China and the devastating bushfire in Australia.

Are you wondering if the year 2020 might not have taken the right start? Dividend stocks could be the answer to that question.

As interest rates in Australia are already at record low levels, find out which dividend stocks are viewed as the most attractive investment opportunity in the current scenario in our report.

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it. OK